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Introduction: Migraine is a debilitating primary headache disorder with a poorly
understood aetiology. An extensive body of literature supports the theory of migraine
as a systemic vascular inflammatory disorder characterised by endothelial dysfunction.
It is also well-known that chronic inflammation results in an excessive burden of
oxidative stress and therefore cellular dysfunction. In this study the effects of excessive
oxidative stress through the phases of female migraine-with-aura (FMA) were evaluated
by examining the health of the systems of haemostasis.
Methods: Blood was obtained from 11 FMA patients at baseline and during the
headache phase of migraine, as well as from 8 healthy age-matched female controls.
Samples were analysed using thromboelastography (TEG) to evaluate viscoelastic
profiles, light microscopy for erythrocyte morphology, Scanning Electron Microscopy
(SEM) for erythrocyte and fibrin clot structure, confocal microscopy for β-amyloid
detection in fibrin clots.
Results: Viscoelastic profiles from platelet poor plasma showed decreased clot reaction
times in FMA at baseline (95% CI [5.56, 8.41]) vs. control (95% CI [7.22, 11.68]); as
well as decreased time to maximum thrombus generation for the same comparison
(95% CI [6.78, 10.20] vs. [8.90, 12.96]). Morphological analysis of erythrocytes indicated
widespread macrocytosis, poikilocytosis and eryptosis in the migraineurs. Analysis
of fibrin networks indicated that this hypercoagulability may be a result of aberrant
fibrin polymerisation kinetics caused by the adoption of a β-amyloid conformation
of fibrin(ogen).
Conclusion: The results reaffirm the hypercoagulable state in migraine, and would
suggest that this state is most likely a result of a systemic inflammatory state
which induces oxidative damage to both erythrocytes and fibrin(ogen) in female
de Villiers et al. Migraine as an Oxidative Fibrinopathy
episodic migraine-with-aura. Furthermore, if the amylodogenic changes to fibrin(ogen)
were observed in a larger cohort, this would support theories of micro-embolisation
in migraine-with-aura.
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INTRODUCTION
Migraine with aura is a debilitating primary headache disorder
diagnosed by specific criteria determined by the International
Headache Society (1). Of greatest significance are the unilateral
pulsatile pain sensation and the transient neurological
disturbances affecting vision, sensation, speech, language
comprehension, or motor skills (1).
The pulsating nature of migraine headache implicates cerebral
vasculature in pathogenesis, and indeed it is known that
altered cortical blood flow in migraine with aura results in the
phenomenon known as Cortical Spreading Depression (CSD)
occurring spontaneously before the onset of headache (1–5).
CSD results from a release of the neurotransmitter glutamate
in a domino effect, which results in a wave of glutamatergic
neuron excitation followed by a wave of inhibition. This results
in the vasodilation of the meningeal vasculature with release
of inflammatory neuropeptides, such as calcitonin gene-related
peptide, substance P, and neurokinin A (3, 6). This inflammatory
process promotes vasodilation of the cerebral arteries and dural
venous sinuses, as well as inducing inflammatory cytokine
production and activation of mast cells and leukocytes. The end
result is the sensitisation of the peripheral nociceptors of the
trigeminovascular system and the headache phase of migraine,
characterised by pulsating pain that is aggravated by any activity
that increases intracranial pressure (7–11).
A model of endothelial dysfunction in the trigeminovascular
system has emerged in migraine research. Endothelial
dysfunction induces an inflammatory response which results
in oxidative stress and a hypercoagulable state marked by
increased platelet reactivity, altered erythrocyte morphology and
metabolism, and increased fibrinogen levels (5–10, 12–14). In
this model it is inherently suggestive that haemostasis would be
affected through the phases of migraine.
Red blood cells can act as free radical scavengers preventing
oxidative damage of body tissues and are unique cellular
indicators of the presence of an inflammatory pathology as well as
the body’s response to such an event (15–17). Prolonged exposure
to oxidative elements results in a greater amount of free radicals
being produced than can be neutralised, leading to oxidative
damage of red blood cells and especially of the phospholipid
bilayer membranes. In pathological states and under oxidative
stress the normally asymmetrical distribution of lipids between
inner and outer sides of the bilayer is disturbed, resulting in
membrane scrambling (16, 18, 19).
The role of fibrin(ogen) in migraine pathophysiology has not
been well-explored (20). Fibrinogen is exceptionally sensitive
to oxidation, serving as a free radical scavenger and protecting
other plasma proteins from damage (21–23). Although vital,
this function results in altered fibrin structure in individuals
suffering from chronic systemic inflammation who are burdened
by greater degrees of oxidative stress. A variety of mechanisms by
which this structural alteration may occur have been proposed,
while the ultimate result is agreed to be densely matted networks
(21, 22, 24).
We thus considered it worthwhile to investigate the
ultrastructure of the fibrin networks of FMA patients, and to
investigate whether the alteration to fibrin networks seen under
oxidative stress might be the result of an amyloidogenic process
active in the pathophysiology of migraine with aura.
Furthermore, we considered the changes that altered cortical
blood flow and recurrent inflammatory dysregulation could have
on rheology. As such we evaluated erythrocyte structure and
platelet activation as vital indicators of overall health in the FMA
cohort (16).
MATERIALS AND METHODS
Study Design
This was a case control observational pilot study. The
primary objective was to determine if the blood of female
episodic migraine-with-aura indicated systemic inflammation
and a state of changing coagulability through the phases of
migraine. Secondary objectives were to evaluate fibrin networks
under scanning electron microscopy for evidence of altered
polymerisation and clotting dynamics; to critically evaluate
erythrocyte morphology for indicators of oxidative stress using
light and scanning electron microscopy of native whole blood; to
evaluate viscoelasticity of whole blood and platelet poor plasma
through the phases of migraine using thromboelastography; and
to determine the presence of β-amyloidogenic alterations to
fibrin fibrils by using confocal microscopy.
Although power calculations were made by a biostatistician of
the Research Office of the Faculty of Health Sciences, University
of Pretoria, sample size was ultimately limited by recruitment
time. Statistical analyses were carried out at the advice of the
biostatistician as two-tailed t-tests and Kruskal-Wallis ANOVA
with Dunn’s post-tests to correct for multiple comparisons.
Red blood cell morphology parameters were additionally
analysed using linear mixed modelling and quantile regression,
respectively, to consider for between-patient variation, using
STATA15. Parameters not conforming to a Gaussian distribution
were analysed by Wilcoxon matched-pairs signed rank tests.
Owing to the nature of the measurement and a current lack
of standards for red blood cell axial ratios, as well as the need
to correct for multiple testing, it was decided to test the axial
ratios at a significance level of 95% (P < 0.05) and then divide
by three for a final P-value of 0.0167. Unless stated otherwise
analyses were performed using GraphPad Prism 6, with minimal
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significance defined as P < 0.05 (CI = 95%) (25–27). Normality
was evaluated using D’Agostino and Pearson tests. Confounding
factors were very strictly excluded from the study in order to
avoid haemostatic or rheological changes that could not be
ascribed to episodic migraine-with-aura or the treatment thereof.
Patients were recruited under informed consent from a private
migraine clinic as well from the staff of the Faculty of Health
Sciences at the University of Pretoria. Inclusion in the study
was dependent on diagnosis as an episodic migraine sufferer
as detailed by the International Headache Classification III
guidelines and under the guidance of a neurologist specialised in
migraine treatment (1). The following exclusion criteria directed
recruitment: age younger than 18 years; smoking; use of chronic
medication other than that which has been prescribed for the
treatment of episodic migraine; prior history of cardiovascular
disease, transient ischaemic attack, asthma or auto-immune
disease. Stage of ovarian and menstrual cycles, and method of
contraception were not controlled for in this pilot. Blood samples
were obtained from the participants “at baseline” (defined here
as the interictal period) and during the headache phase of a
migraine attack.
Viscoelasticity
Thromboelastography was performed on whole blood and on
platelet poor plasma (obtained by centrifugation of citrated
native blood and thawed after storage at −80◦C) at baseline
and during the headache phase of migraine using a TEG 5000
computer-controlled device (Haemonetics Corp., Niles, IL, USA)
and following manufacturer’s instructions. This method was used
to monitor the viscoelastic profiles of migraineurs at baseline and
during the headache phase of migraine.
Erythrocyte Morphology
Whole blood collected in citrate tubes was analysed under light
and scanning electronmicroscopy. Methylene blue/eosin (MB/E)
differentially stained peripheral blood smears were viewed under
a 100 X oil-immersion objective of a Zeiss AXIO Imager M2.
Cellanyzer v 1.1 software was used to determine axial ratios and
circumferences of red blood cells. SEM samples were viewed
using a Zeiss Cryo CR-Beam Ultra-resolution SEM at 1 kV.
Fibrin Morphology and Amyloidogenesis
Fibrin(ogen) structure and polymerisation kinetics were
investigated using scanning electron microscopy and fluorescent
microscopy for amyloid mutation. Fibrin clots were prepared
for SEM by the addition of reconstituted human thrombin
to platelet poor plasma (PPP). Clots were viewed under 35 k
magnification using a Zeiss Cryo CR-BeamUltra-resolution SEM
at 1 kV magnification and were analysed for 8-bit pixel intensity
using the histogram function of Image J v2.0 FIJI (National
Institutes of Health, USA). Amyloid fibrils show an unbranched
ribbon morphology consisting of laminated β-sheets running
perpendicular to the long axis. It is this structure that allows for
the binding of the benzothiazole dye Thioflavin T(ThT), a potent
in vitro fluorescent marker when bound to amyloid fibrils. Where
detection of amyloid by fluorescent microscopy is concerned
ThT has shown superiority over congo red and methyl violet,
showing increased sensitivity and efficiency, with enhanced
excitation maximum (450 nm) and wide emission spectrum
of 508 to 570 nm (28). Fibrinogen was treated by addition
of thioflavin T to a final concentration of 0.025 mmol/µl
(Abcam, ab120751). Fibrin clots were prepared by addition of
thrombin to the treated PPP. Clots were viewed under 63 X
oil-immersion objective of a Zeiss LSM 880 with Airyscan using
the 488 nm laser with a 458 nm excitation filter to overcome a
reflectance issue.
RESULTS
A total of thirteen female migraineurs with aura episodic
migraineurs were recruited for participation in this study. Of
these individuals, one was excluded owing to the later diagnosis
of a medical condition that met exclusion criteria, while another
was lost to follow-up. Mean age of the remaining eleven was 37.4
± 12.1 years, with average age of migraine with aura onset of
18.6 ± 7.6 years at an average frequency of 2.9 ± 1.5 migraines
per month. The participants subjectively rated their pain levels
on a scale of 1 (lowest intensity) to 10 (highest intensity).
Using this system the participants scored mild migraines an
average of three, while severe headaches were scored an
average of nine. Regarding aura symptomatology: 90.9% reported
visual disturbances, 81.8% reported sensory disturbances, 54.5%
reported motor disturbances, 36.4% reported difficulty speaking,
and 18.2% reported difficulty understanding speech. Mean age of
the female controls was 39.9± 11.4 years.
Viscoelasticity
Nine TEG R© parameters were measured to determine the
viscoelastic profiles of healthy controls and FMA patients. The
tracings produced, their interpretation, and the nine parameters
of interest are shown in Figure 1 (29, 30). No significant
differences were found in whole blood samples drawn during the
headache phase or baseline compared to healthy age-matched
controls. Analysis of PPP samples found clot reaction time
(R) in minutes as well as time to maximum rate of thrombus
generation (TMRTG) in minutes to be significantly decreased in
female migraine-with-aura at baseline compared to healthy age-
matched controls (P < 0.05). Results have been summarised in
Supplementary Table 1 and Figure 2.
Erythrocyte Morphology
Axial ratios (major axis: minor axis, arbitrarily determined) are
used to compare red blood cell shapes while circumferences are
used to compare red blood cell sizes. Examples of Cellanyzer
v 1.1 axial ratio and circumference determination are shown
in Figure 4.
Circumferences of erythrocytes were measured as number of
pixels (Figure 4). Analysis of circumferences by Kruskal Wallis
with Dunn’s post-test were found to be increased during the
headache phase (P < 0.0001) of migraine (95% CI [148.00,
149.10]) compared to healthy age-matched controls (95% CI
[142.30, 143.40]). There were no significant differences in
circumference between headache phase and baseline. A linear
model with a random intercept for each of the patients in the
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FIGURE 1 | Interpretation of the TEG® tracing (blue in A), velocity curve (blue in B), and parameters produced for FMA at baseline and headache phase compared to
age-matched healthy controls. The velocity curve parameters (MRTG, TMRTG, and TTG) are calculated using the G value of the TEG® tracing.
female control group, the FMA baseline group as well as the
FMA headache phase group (24 subjects), with robust standard
errors was used to model circumference in order to consider
for between-patient variation. The means of circumference for
each of the three groups were estimated from the model. Tests
were conducted to test the equality of the migraine group effects
after the models were run, which found RBC circumferences
to be significantly greater in the headache phase compared to
control (P = 0.013) as well as compared to baseline (P = 0.0290)
(95% CI [140.16, 154.87]). Results of Cellanyzer v 1.1 analysis are
summarised in Table 1 and Figure 3.
It was found that the axial ratios of red blood cells of the
female migraineurs were increased during the headache phase
(95% CI [1.53, 1.58]) of migraine compared to healthy age-
matched controls (95% CI [1.39, 1.44]) (P < 0.0001); with no
significant change in axial ratios from baseline to the headache
phase A quantile regression model, modelling the median, with
robust standard errors was used to model axial ratio in order
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FIGURE 2 | Tukey box plots for clot reaction time (R, min) and time to maximum thrombus generation (TMRTG, min). Both parameters were significantly decreased in
PPP samples obtained from migraine at baseline compared to PPP from healthy age-matched controls.
to account for non-normality, outliers and for the fact that not
all observations are independent. Tests were conducted to test
the equality of the migraine group effects after the models were
run, which found axial ratios to be significantly greater during
the headache phase compared to control (P < 0.0001) as well as
compared to baseline (P < 0.0001) (95% CI [1.36, 1.47]).
This would indicate that the red blood cells of migraineurs
show deviation from the normal discoid shape producing cells
that are elongated along the major axis around the time of a
headache attack.
Having used light microscopy to establish that the red blood
cells of migraineurs were of a significantly different size and shape
from those of healthy individuals, we studied this further using
both light microscopy and themore sensitive method of scanning
electron microscopy.
Red blood cells were considered in terms of shape, size, colour,
inclusions, and arrangement. Analysis under light microscopy
(Zeiss AXIO Imager M2, 100 X) and SEM (Zeiss Cryo CR-
Beam Ultra-resolution SEM) showed widespread poikilocytosis
throughout the FMA cohort at baseline and persisting into the
headache phase compared to age-matched healthy individuals.
Poikilocytosis is the presence of abnormally shaped red blood
cells which often occurs with anisocytosis—the presence of
unequally sized red blood cells. The various alterations of
red blood cell morphology seen under light microscopy are
illustrated in Figure 4.
Scanning electron microscopy analysis of whole blood was
used to further analyse red blood cell morphologies in samples
drawn from the female migraine sufferers at baseline and
during headache phase. The various alterations from normal
morphology (Figure 5) are shown in Figure 6. The membranes
of migraineur erythrocytes ranged from the normal, healthy
undulating quality to membranes that were granular in texture
or were marked by pitting defects. Increased red blood cell
aggregability as well as protein adhesion on red blood cells
indicated changes in the electrical potentials across these red
blood cell membranes. The red blood cells of females affected
by migraine with aura were furthermore widely characterised
by the loss of the normal discoid shape. Of special interest was
the much increased presence of erythrocytes in various stages of
eryptosis (17)—programmed suicide of erythrocytes that can be
signalled for by excessive oxidative stress because of persistent
systemic inflammation.
Analysis under SEM indicated that the platelets of migraineurs
were innately activated with several forming dense aggregations
reminiscent of the beginning of a platelet clot. In several native
whole blood migraineur samples (i.e., without addition of clot-
inducing reagents, such as thrombin) fibrin fibres were found.
The combined evidence of extraordinary platelet activation and
innate fibrin polymerisation indicate innate activation of the
coagulation cascade in episodic migraine.
Fibrin Morphology and Amyloidogenesis
It was found that the fibrin network micrographs of female
migraineurs at baseline (95% CI [0.77, 0.84]) have slightly
decreased coefficients of variation compared to those of healthy
age-matched controls (95% CI [0.80, 0.84]), with significantly
decreased coefficients of variation during the headache phase
(95% CI [0.72, 80]) (P < 0.0001). Decreased variation indicates
fewer black pixels (absence of fibrin) compared to grey pixels
(fibrin) and thus denser fibrin networks. Furthermore, it was
found that there was significant difference in the density of fibrin
networks formed from baseline PPP and headache phase PPP
(Table 2). Example micrographs with corresponding histograms
are shown in Figure 7.
Confocal micrographs of ThT-treated fibrin clots taken at 63
X were analysed for 8-bit pixel intensity using the histogram
function of FIJI. Example micrographs with corresponding
histograms are shown in Figure 8.
Confocal microscopy was first used to view fibrin clots under
transmitted light (405 nm) before fluorescence was observed at
an excitation wavelength of 488 nm. It has been found that
amyloid proteins autofluorescence (31), and this was assessed in
order to detect any foci of fibrin autofluorescence (32), and also
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TABLE 1 | Summary of results of light microscopy for red blood cell axial ratios and circumferences.
RBC axial ratios: D’Agostino and pearson: P < 0.0001
RBC AXIAL RATIOS: MANN-WHITNEY TEST
Group P-value
Female control vs. FMA BL 0.0107
Female control vs. FMA HP <0.0001
WILCOXON MATCHED-PAIRS SIGNED RANK TEST
Baseline group Headache phase group P-value Correlation coefficient
FMA BL FMA HP >0.9999 Spearman −0.1141
QUINTILE REGRESSION MODEL FOR CONDITIONAL MEDIAN OF AXIAL RATIOS
Group Beta (95% CI) P-value
FMA baseline 1.33 (1.31, 1.34) 0.2620
FMA headache phase 1.42 (1.39, 1.44) <0.0001
Intercept 1.31 (1.29, 1.33) <0.0001
RBC circumference: D’Agostino and pearson: P < 0.0001
RBC CIRCUMFERENCE: KRUSKAL-WALLIS ANOVA
Group P-value
Female control vs. FMA BL vs. FMA HP <0.0001
Median (25%; 75%) Control group Migraine group P-value
BASELINE: DUNN’S POST-TEST
Female control 142 (136; 148) FMA BL 142 (136; 150) 0.4223
HEADACHE PHASE: DUNN’S POST-TEST
Female control 142 (136; 148) FMA HP 147 (140; 155) <0.0001
WILCOXON MATCHED-PAIRS SIGNED RANK TEST
Baseline group Headache phase group P-value Correlation coefficient
FMA BL FMA HP >0.9999 Spearman 0.0587
LINEAR MIXED MODEL WITH RANDOM INTERCEPTS FOR CIRCUMFERENCES
Group Beta (95% CI) P-value
FMA baseline 143.51 (141.04, 145.99) 0.545
FMA headache phase 147.52 (144.91, 150.11) 0.0113
Intercept 142.26 (139.04, 145.48) <0.0001
The significant values to be in bold.
to determine whether these foci corresponded with fluorescence
from ThT binding to areas of β-amyloid misfolding. Some images
are shown in Figure 8 and indicate that auto-fluorescent foci are
indeed areas of β-amyloid misfolding.
Analysis showed that the fibrin clots of female migraineurs
with aura had significantly higher numbers of amyloid fibrils rich
in β-sheets at baseline (95% CI [0.80, 0.99]) than did healthy age-
and gender-matched controls (95% CI [0.99, 1.16]) (P < 0.001).
This did not persist into the headache phase (95% CI [1.00, 1.21])
and the presence of amyloid fibrils rich in β-sheets was found to
be significantly different between baseline and headache phase.
Results are summarised in Table 2.
DISCUSSION
The results of TEG R© analysis of the viscoelastic profiles
of the female migraineurs through the phases of migraine
compared to healthy age-matched controls indicate that migraine
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FIGURE 3 | Tukey box plots of the red blood cell (RBC) axial ratios and circumferences of female migraine with aura patients compared to age-matched controls.
is accompanied by a hypercoagulable state with pronounced
hypercoagulability during the headache phase. These results echo
the work of Nielsen (33) and Tietjen and Collins (5).
Tietjen and Collins (5) and Tietjen (7, 12) described amodel of
migraine pathogenesis whereby migraine gives rise to endothelial
dysfunction in the arteries closely associated with the trigeminal
nerve, promoting a hypercoagulable inflammatory state which
induces further endothelial dysfunction and recurring episodic or
chronic migraine (5, 7, 12). This was supported by Nielsen et al.
(33) who reported that chronic migraineurs showed significantly
decreased clotting initiation times, increased velocity of clot
formation and greatly increased clot strength, all of which
indicate a hypercoagulable state in chronic migraine. Virchow’s
Triad has been used in medicine and pathology since the 1900’s
to define the cause and risk for thromboembolism within three
parameters, namely endothelial dysfunction, hypercoagulability,
and stasis (34, 35). Stasis, such as may be experienced during
immobility or under anaesthesia, is considered a transient risk
factor (34). As such, evaluation of thromboembolic risk in
migraine patients relies on evaluating endothelial function and
coagulability (35).
The significant differences in the whole blood of headache
phase indicated that clot strength, clot elasticity and the
shear elastic modulus strength of clots are greater during
the headache phase of migraine with aura, with decreased
clotting times. In simple terms, patients experiencing a migraine
headache are at risk of forming rapidly growing, large,
strong clots that are more resistant to being deformed or
broken down.
Changes in red blood cell morphology can manifest as
variation in size (microcytic, normocytic, macrocytic), variation
in distribution (rouleaux formation and agglutination) and
shape variation (poikilocytosis) (16). Lippi et al. (6) suggested a
model whereby erythrocytosis promotes hyperviscosity, hypoxia,
and vasoconstriction in migraine. Based on their model it is
plausible that the changes to erythrocyte morphology which
we observed here may contribute to the hypercoagulability we
have noted in the TEG results. Analysis of axial ratios and
circumferences of female migraineur erythrocytes quantitatively
proved macrocytosis and shape variation in episodic migraine.
Shape variation was further qualitatively proven through
morphological analysis. Our results echo those of Celikbilek
et al. (36), who reported higher red cell distribution width
in migraine.
Poikilocytosis, in its various forms, can be a sign of a variety
of conditions including advanced liver disease, hyposplenism,
pyruvate kinase deficiency, anaemia of various origins, oxidative
haemolysis, renal failure, and haemoglobinaemias (37, 38). This
is a result of the sensitivity of red blood cells to pathology, a
characteristic which makes them useful as health indicators (16).
A diagnosis of a specific condition would require a predominance
of a form of poikilocytosis. The presence of polymorphism
in the migraine cohort makes it more likely that a chronic
inflammatory state exists in migraine causing biochemical and
biophysical disruptions to erythrocyte metabolism, function
and morphology (16). Pretorius et al. (16) define biochemical
changes as those affectingmolecular arrangement andmembrane
ultrastructure, while biophysical changes affect shape and
elasticity or rigidity. Biochemical changes lead to biophysical
changes (16). It is thus the biophysical properties of red
blood cells that determine deformability and rheology. The
changes seen under light microscopy in the red blood cell
morphologies of migraine patients mostly indicated biophysical
changes, however, agglutination and microrouleaux formation
(i.e., variations in distribution) indicate aberration at the
biochemical level.
One of the protein classes maintained in the erythrocyte
membrane by cholesterol are the sialylated glycoproteins.
These glycoproteins are responsible for the negative electric
potential across the cell membrane, and thus the repulsive
forces between red blood cells that allow for passage of
individual cells through the microvasculature (18, 39). If
pathological changes affect the sialylated glycoproteins the
negative membrane potential may be lost and erythrocytes
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FIGURE 4 | MB/E blood smears of red blood cells with major axis, minor axis, and circumference determined by Cellanyzer software. (A) Female control, (B) female
migraine aura baseline, (C) female migraine aura headache phase. Aberrant erythrocyte morphologies widespread in the migraine population. (D) Helmet cell; (E)
teardrop cell; (F) irregularly contracted cell; (G) elliptocytes; (H) echinocyte; (I) acanthocytes (spur cells); (J) microrouleaux formation; (K) microrouleaux with surface
projections; (L) RBC Agglutination.
become attracted to each other, and in the case of rouleauxs,
become “stacked” (40). This and other biochemical changes
which affect the cell membrane result in altered flexibility
and decreased movement of cells through the microvasculature
(16, 39). The major causes of widespread variation in size,
shape and distribution are oxidative stress (which is in line
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FIGURE 5 | Healthy control red blood cell morphology. (A) A healthy red blood cell is discoid in shape with a large biconcave central indentation. (B) The external
surface of the membrane has an undulating quality.
with the model suggested by Lippi et al.) and upregulation
of inflammatory molecules following hyperosmotic shock; both
processes accompany chronic systemic inflammation and lead to
eryptosis (6, 13, 16–19).
Eryptosis is the programmed suicidal cell death of
erythrocytes, occurring in the absence of mitochondria or
nuclei. Eryptosis is predominantly triggered by exposure
to reactive oxygen species and hyperosmotic shock.
Hyperosmotic shock activates the cyclooxygenase (COX)
enzyme system as well as phospholipase A2 (PLA2). COX
activation leads to production of prostaglandin E2 (PGE2),
which in turn causes the opening of calcium permeable
non-selective cation channels. PLA2 activation leads to
release of platelet activating factor (PAF) and later ceramide
production. Ceramide increases calcium sensitivity of the cell
(15, 17, 41).
Oxidative stress also increases calcium entry through cation
channels (via PGE2 action). The net calcium influx following
oxidative stress and hyperosmotic shock leads to the activation
of calpain; the translocation of phosphatidylserine to the outer
membrane leaflet, i.e., the “PS flip”; and the activation of
potassium and chloride channels. The PS flip in combination
with the activation of calcium permeable non-selective cation
channels via PGE2 leads to the first stage of eryptosis,
cell membrane scrambling. Calpain is an endopeptidase that
degrades membrane proteins, resulting in the second stage of
eryptosis, membrane blebbing. Lastly, net eﬄux of potassium
and chloride causes membrane hyperpolarisation and the net
loss of water, leading to the last stage of eryptosis, cell shrinkage
(15, 17, 41).
In contrast to those of controls, cells in all three stages
of eryptosis—membrane scrambling, cell shrinkage and
membrane blebbing—were widespread both at baseline and
during the headache phase of migraine as evidenced using
scanning electron microscopy. The cumulative evidence
of the analysis of whole blood cells supports the theory of
migraine as a chronic systemic inflammatory condition,
which both results from and will produce high levels of
oxidative stress (16). Several factors affect coagulability of
both healthy individuals and those suffering from disease
conditions. Advancing age, female gender, combined oral
contraceptive use, and low-normal haematocrit are known to be
procoagulant (42).
Investigation by scanning electron microscopy furthermore
indicated increased platelet activation in this cohort, although
platelet function was not a main endpoint for our study.
Borgdorff and Tangelder (43) proposed that increased platelet
activation, reactivity and aggregability in the headache phase
of migraine plays a vital role not only in thromboembolic
risk in migraine but also in the degree of vasoconstriction
owing to serotonin release from platelets (43). It is also
known that platelet activation during blood coagulation
results in the release of the glycoprotein thrombospondin
which co-polymerises with fibrin, possibly modulating
clot structure (23). With platelets affecting both rheology
and coagulability it may of great use to further investigate
the role of platelet activation in migraine-with-aura at a
later time
From the perspective of Virchow’s Triad the results
of viscoelastic analysis would suggest significant risk of
thromboembolism in FMA patients during the headache phase
of migraine, as is supported by the evidence of biochemical and
biophysical changes to erythrocytes. Future enquiry would need
to determine how shear modulus and elasticity could be inferred
to seek to quantitate the risk for embolisation. It has recently
been shown that microembolisation may be the cause of cortical
spreading depression experienced in migraine with aura, and
may be the causative link between migraine and a variety of
cerebrovascular disorders (4). The hypercoagulable viscoelastic
profiles of migraineurs, especially those measured during the
headache phase, support the possibility of microembolisation as
per Virchow’s triad.
Following changes in primary structure (such as seen with
fibrinogen oxidation) or under great mechanical stress the
tertiary structure of fibrinogen can be altered from mainly α-
helices to mainly β-sheets. This same alteration in architecture
has been seen in other proteins undergoing amyloidogenesis
(44). Amyloidogenesis is the process whereby protein misfolding
gives rise to insoluble proteinaceous fibrils. This process has
been implicated in various conditions, such as Alzheimer’s,
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FIGURE 6 | Whole blood of female migraineurs with aura through the phases of migraine. RBC membrane surface ranged from the normal undulating quality (A) to
granular in texture (B) and membranes with pitting defects (C). The presence of pathological erythrocyte morphologies was widespread and included leptocytes (D),
stomatocytes (E), and elliptocytes (F). The greatest marker of pathology was the increased presence of RBCs in various stages of eryptosis (G–I) compared to
healthy age-matched controls. Increased RBC aggregability was also seen (F,J,K) as well as protein aggregation on RBC surfaces (J–L). Platelets were also found to
be innately activated in whole blood samples of migraineurs, with many forming dense aggregations and platelet thrombi (M–O).
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FIGURE 7 | SEM Micrographs of female fibrin clots and corresponding histograms of 8-bit pixel intensity. (A) Healthy female control, (B) female migraineur with aura
at baseline, (C) same female migraineur during headache phase.
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TABLE 2 | Summary of results of 8-bit pixel intensity coefficient of variation analysis of SEM micrographs and of confocal micrographs of fibrin clots treated with the
amyloid marker ThT.
SEM analysis of fibrin network density
Mean ± SEM Control group Migraine group P-value Significant
BASELINE
Female control 0.8207 ± 0.0106 Female migraine aura 0.8059 ± 0.0168 0.4885 No
HEADACHE PHASE
Female control 0.8207 ± 0.0106 Female migraine aura 0.7577 ± 0.0196 0.01 Yes
Baseline group Headache phase group P-value Significant Correlation coefficient
PAIRED ANALYSIS
Female migraine aura Female migraine aura 0.0331 Yes r 0.2698
Confocal analysis of β-amyloid composition of fibrin networks
Median (25%; 75%) Control group Migraine group P-value Significant
BASELINE
Female control 1.03 (0.95; 1.19) Female migraine aura 0.80 (0.69; 1.00) 0.0002 Yes
HEADACHE PHASE
Female control 1.03 (0.95; 1.19) Female migraine aura 1.00 (0.84; 1.32) 0.52 No
Baseline group Headache phase group P-value Significant Correlation coefficient
PAIRED ANALYSIS
Female migraine aura Female migraine aura 0.0006 Yes Spearman rs 0.1407
The significant values to be in bold.
prion diseases, and the systemic amyloidosis (28). It has been
demonstrated that the β-Amyloid formed in Alzheimer’s disease
associates with the β-chain C termini fibrinogen inducing
oligomerisation and resulting in the formation of structurally
abnormal fibrin fibrils with the resultant fibrin clots being
resistant to fibrinolysis (45, 46). Recent work by Pretorius
et al. has indicated that the addition of substoichiometric
levels of Gram-negative bacterial lipopolysaccharide (LPS),
lipoteichoic acid (LTA) from Gram-Positive bacteria as well
as molecules like iron, may in part, induce amyloidogenesis
during blood clotting. Ultrastructural analysis implied that in
this amyloidogenic state fibrin was in an autocatalysed β-
sheet-rich form that resembled what had been seen in plasma
from individuals with inflammatory and amyloid diseases,
indicating LPS, as one of the possible reasons for misfolding of
fibrinogen that any point the possibility that LPS might have an
etiological involvement (44, 47, 48). However, a systems biology
approach must be taken when unraveling the protein misfolding
process, as the involvement of bacterial inflammagens and
other dysregulated inflammatory molecules in disease etiology is
complex and rarely the result of a single dysregulated molecule
or event.
The oxidative damage seen in this cohort reflects the pattern
of ozone oxidation described by Rosenfeld et al. (21). According
to this model, oxidisation results in the formation of reactive
functional groups and conformational changes of the D regions
of fibrinogen. This in turn exposes new reaction sites allowing for
auto-catalysation with inhibition of longitudinal polymerisation.
Fibrin thus polymerises in a tail-to-tail pattern as opposed to
the normal middle-to-tail pattern (21, 49). In this cohort, these
changes may be attributable to β-amyloidogenic misfolding of
the tertiary structure of fibrin as shown by ThT binding under
confocal microscopy.
Elasticity and stiffness of fibrin networks are conferred
through factor XIII-catalysed α-α crosslinking between
individual fibres, which promotes lateral aggregation and
formation of branching points (21, 49–51). As such it would
be expected that fibrin networks rich in β-amyloidogenic
misfolded protein fibrils would exhibit decreased elasticity
with decreased lateral aggregations and branching points—as
described in the oxidation model described by Weigandt et al.
(22) However, it has been established that the blood clots formed
in amyloidogenic states are resistant to degradation by tissue
plasminogen activator (tPA) (45, 52). reflecting the insoluble
nature of the proteinaceous fibrils (28, 45, 46). Thus, the
findings presented here support the microembolisation theory
of migraine described by Dalkara et al. (4), and are summarised
in Figure 9.
Following previous work into the causative role of bacterial
inflammagens in amyloidogenesis it may be valuable to
investigate the possibility of a link between migraine and
conditions of gut dysbiosis, which are characterised by
elevated serum levels of bacterial LPS and other such related
molecules (53–55).
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FIGURE 8 | Unstained fibrin clots in comparison to ThT treated fibrin clots with histograms of 8-bit pixel intensity for a healthy control (A,B), female migraine-with-aura
at baseline (C,D) and female migraine-with-aura during the headache phase (E,F). Beta-amyloid visibility was far improved by addition of ThT to PPP, as seen in (D,F).
Further advancement of this study would be achieved by
increasing the sample size, using the TEG data as a guide at
least 48 participants would be required to have a 90% power to
detect a 15% difference between the female episodic migraine-
with-aura and control groups. Stage of ovarian and menstrual
cycles, as well as contraceptive method, could also be controlled
for in a larger cohort. Furthermore, we would aim to improve
the quality of a larger study by evaluating confounding variables,
such as obstetric history, body mass index, serum lipid profiles
and hypertension.
CONCLUSION
In this pilot study, morphological analysis of the whole
blood of female migraineurs with aura is suggestive of a
systemic inflammatory state both at baseline and during the
headache phase characterised by macrocytosis, poikilocytosis
and eryptosis. The observed variations in erythrocyte size,
shape and distribution are most likely a result of oxidative
stress. This observed inflammatory pathology is the likely
cause of the known hypercoagulability in FMA, which was
most prominently observed in this cohort during the headache
phase. This hypercoagulable state may be a result of aberrant
fibrin(ogen) polymerisation kinetics; which if present in a
larger cohort would support theories of micro-embolisation
in migraine with aura. Another trend indicated by the
viscoelastic analysis of episodic female migraine-with-aura is
that hypercoagulability is more pronounced in platelet poor
plasma than in whole blood. This would suggest an inherent
change in both fibrinogen and fibrin in these migraineurs,
possibly as a result of the oxidative stress evidenced in the
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FIGURE 9 | Endothelial dysfunction, hypercoagulability and stasis in FMA support the theory of microembolisation described by Dalkara et al. (4) as per Virchow’s
triad (VT). Evidence of amyloidogenic blood clotting would further indicate that such microemboli are resistant to degradation.
red blood cells of these patients. It is known that oxidative
damage to fibrinogen can result in a protein misfolding with
changes to its tertiary structure visible with confocal microscopy
as both auto-fluorescent and amyloid areas, and in SEM as
denser and matted fibrin areas. This suggests that in women
with episodic migraine-with-aura, abnormal blood clotting takes
place. Hopefully, this knowledge may lead to novel diagnostics
and therapeutics.
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